Local Delivery of IFN{alpha} Has Antitumor Activity in Bladder Cancer [Clinical Trials]

Intravesical delivery of rAd-IFNα/Syn3 is safe and achieves durable responses in high-grade NMIBC.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Clinical Trials Source Type: research